Video summary
High Paying Non Clinical Jobs for MBBS Doctors | No NEET PG and FMGE ❌ | Live Free Webinar
Main summary
Key takeaways
Main ideas, concepts, and lessons
1) Purpose and framing of the webinar
- The session is promoted as a “live free webinar”, positioned as free for the medical fraternity.
- Its purpose is to create awareness about high-paying non-clinical careers for MBBS/MD doctors.
- Organizers emphasize that many doctors:
- enter medicine due to passion or family pressure, and
- feel stuck after MBBS/MD because clinical-only paths can be demanding (e.g., reliance on NEET PG / FMGE, plus long hours, night shifts, and heavy responsibilities).
- Core thesis: clinical practice is not the only path—there are better/smarter alternatives in industry and pharma-related roles.
2) Organization/brand positioning (Academically)
- The webinar is conducted by a team associated with Academically.
- Key claims about Academically include:
- Mission: help healthcare professionals build better high-paying careers and access global opportunities
- Support for international licensing exam pathways (examples mentioned: Australia and Gulf countries)
- “Stats-based” credibility claims:
- 1 million+ digital presence
- 82+ countries
- 200+ institutional partners
- 10,000+ students globally
- Mentions an alumni network across healthcare professions
3) Founder/mentor motivation and narrative (why non-clinical roles)
- Dr. Akram shares:
- His background in starting Academically and supporting international transitions
- Stories of doctors moving into non-clinical roles and achieving high salaries
- The recurring motivation: clinicians may earn well but often lack time for themselves, experience shift work, and feel overworked—non-clinical roles are framed as improving work-life balance.
4) Expert panel consensus: why non-clinical roles can be attractive
Across speakers, the repeated benefits include:
Work-life balance
- More structured schedules
- Less exposure to night shifts / emergency calls compared to clinical practice
Pay and career growth
- Industry roles are described as offering higher earning ranges, including claims such as “20–40 lakhs per annum” (noted as varying by role/experience during Q&A)
Multiple domains / role variety
- Non-clinical paths are presented as broad and customizable based on personality, skills, and preferences
Travel / remote work options
- Some roles include travel (e.g., MSL/medical affairs-related work)
- Others may allow remote/work-from-home, depending on company policy
Methodology / structure taught (program pathway and selection process)
A) Non-clinical role map presented in the webinar
The presentation emphasizes a list of non-clinical job functions:
- Medical Affairs / Medical Science Liaison (MSL)
- HEOR – Health Economics & Outcomes Research
- Patient Safety Physician (also discussed as Medical Monitor / Medical Reviewer)
- Medical Writing / Medical Marketing (overlap in terminology; discussed as related functions)
- Clinical Drug Development
- Healthcare Data Analytics
B) Details of specific role functions (as explained)
1) MSL (Medical Affairs / Medical Science Liaison)
- Core function:
- Acts as a scientific communicator
- Translates complex clinical/research data into insights for:
- Key Opinion Leaders (KOLs)
- conferences/meetings/expert discussions
- Purpose framing:
- Supports trusted leadership and evidence-based product/medical strategy
- Example given: a “Drug A replaced by Drug B” scenario due to newer evidence—MSL is positioned as the person who credibly communicates updated evidence, not just promotes brands
2) Drug Safety Physician / Medical Reviewer (patient safety-related)
- Primary responsibilities described:
- Adverse event assessment (ADR/AE reports)
- Signal detection and risk management
- Prepare/review regulatory documents to meet standards (examples named: FDA/EMA/CH)
- Provide medical guidance to pharmacovigilance teams and support cross-functional coordination
3) HEOR (Health Economics and Outcomes Research)
- Primary responsibilities described (data and modeling oriented):
- Data mining in evidence/market access contexts
- Evaluate cost-effectiveness, utility, and budget impact
- Cost-minimization and economic comparison studies
- Data modeling and building economic models
- Designing real-world evidence / project work
C) “Academically” program: how they claim to make candidates “job-ready”
The webinar claims a job-ready curriculum plus a selection funnel.
Placement-oriented training elements mentioned
- CV/cover letter generation
- Interview preparation guidance
- Mock interviews
- LinkedIn optimization
- CV overhaul
- Simulations (examples cited):
- medical strategy briefing
- adverse event simulation
- Mentorship and faculty support from:
- industry experts
- the expert panel (e.g., Dr. Nishta, Dr. Malini mentioned)
- Placement support is strongly emphasized
Program structure and timing
- Mention of an intensive curriculum:
- 4-month curriculum
- live interactive sessions
Admission / enrollment process (step-by-step)
- After the webinar:
- People who shared a link are contacted by the counseling team
- Enrollment flow described:
- Admission test (required)
- Interview round
- Offer if the candidate matches job-description needs
- Candidate joins the batch after paying fees
Key eligibility mapping mentioned
- MSL eligibility
- Generally MBBS/MD/MS (also pharmacy/dentistry/allied paths mentioned)
- Communication and presentation skills emphasized
- Drug Safety / Medical Reviewer
- Attention to detail emphasized
- MBBS/MD/MS profiles considered suitable
- HEOR
- Analytical skills
- Emphasis on biostatistics/math orientation
Instruction-style details given during Q&A (practical advice)
1) Age and “abroad vs India” logic
- They explain:
- “There is no single age limit” for nonclinical jobs in general
- but going abroad (exam/licensing pathways) may introduce practical age constraints
- Australia-focused guidance included:
- Mention of the AMC pathway and English requirement
- One statement referencing “for abroad… age below 45” (spoken as a criterion)
2) Experience and certificate legitimacy
- Repeated emphasis:
- Only officially recognized/registered clinical experience counts for certain eligibility discussions
- “Under-the-table” hospital work may not be considered valid clinical experience for some pathways
3) Resume-building suggestions
- For candidates with gaps or weaker clinical verification:
- Improve CV using:
- CME/CPD points
- clinical/observership ideas (Australia observership mentioned)
- clinical research exposure and trial/clinical research background (where relevant)
- Improve CV using:
4) Job search and tools
- They mention a dedicated jobs platform and encourage using it:
- jobs portal (named in a “jobs.com”-style reference)
- Encourage scanning QR codes / joining a WhatsApp community for job access
Key numeric and fee details explicitly stated
- Course fee mentioned in one Q&A exchange:
- ₹1,50,000 + GST (18%) (India)
- AU$3,000 + 10% GST (international students, as stated)
- Seats:
- “First batch / super 30” concept with limited seats (30)
- Training duration:
- 4 months
- Placement claim:
- Strong emphasis on placements being arranged/guaranteed for the first batch (exact legal wording not fully clear in subtitles)
Main speakers / sources featured (with roles)
Hosts / organizers
- Dr. Sonel (host/presenter; introduces team and panel)
Founder / guide
- Dr. Akram (PhD; founder/mentor; provides origin story + Q&A answers; discusses AMC and nonclinical transitions)
Expert panelists (guests)
- Dr. Nisha Khatri (MBBS, MD Pharmacology; MSL/nonclinical expert; ~7+ years industry experience)
- Dr. Malini Anand (MBBS/EP/MH mentioned; education across Bahrain/UK; transitioned to edtech; discusses motivations plus public health/governance aspects)
Additional contributors mentioned during Q&A / references
- Audience members ask questions (not treated as panel experts unless clearly identified)
- References to external institutions and pathways:
- AMC (Australia Medical Council) exam pathway
- Comparisons referencing USMLE / PLAB / AMC
- Regulatory bodies mentioned for role explanations: FDA, EMA, CH (examples)
- Source branding used throughout:
- Academically
Rate this summary
Your feedback will help improve summaries.
Improve this summary
Reprocess with a stronger model when the summary feels incomplete or inaccurate.
Translate summary in another language
Ask questions to this video
Chat for follow-up questions, clarifications, and source-backed answers.